Related references
Note: Only part of the references are listed.Delivering CRISPR: a review of the challenges and approaches
Christopher A. Lino et al.
DRUG DELIVERY (2018)
Triple Vectors Expand AAV Transfer Capacity in the Retina
Andrea Maddalena et al.
MOLECULAR THERAPY (2018)
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
Janice S. Chen et al.
SCIENCE (2018)
Direct observation of DNA target searching and cleavage by CRISPR-Cas12a
Yongmoon Jeon et al.
NATURE COMMUNICATIONS (2018)
Translation of CRISPR Genome Surgery to the Bedside for Retinal Diseases
Christine L. Xu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2018)
Structural Basis for the Canonical and Non-canonical PAM Recognition by CRISPR-Cpf1
Takashi Yamano et al.
MOLECULAR CELL (2017)
Extending the Host Range of Bacteriophage Particles for DNA Transduction
Ido Yosef et al.
MOLECULAR CELL (2017)
Engineered Cpf1 variants with altered PAM specificities
Linyi Gao et al.
NATURE BIOTECHNOLOGY (2017)
Gene therapy with helper-dependent adenoviral vectors: lessons from studies in large animal models
Nicola Brunetti-Pierri et al.
VIRUS GENES (2017)
In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni
Eunji Kim et al.
NATURE COMMUNICATIONS (2017)
CRISPR-Mediated Integration of Large Gene Cassettes Using AAV Donor Vectors
Rasmus O. Bak et al.
CELL REPORTS (2017)
Effect of PCSK9 Inhibitors on Clinical Outcomes in Patients With Hypercholesterolemia: A Meta-Analysis of 35 Randomized Controlled Trials
Aris Karatasakis et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Highly efficient gene inactivation by adenoviral CRISPR/Cas9 in human primary cells
Olaf Voets et al.
PLOS ONE (2017)
Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
Michael F. Naso et al.
BIODRUGS (2017)
Gene Therapy 2017: Progress and Future Directions
A. M. Keeler et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2017)
Potential pitfalls of CRISPR/Cas9-mediated genome editing
Rongxue Peng et al.
FEBS JOURNAL (2016)
Targeted Gene Manipulation in Plants Using the CRISPR/Cas Technology
Dandan Zhang et al.
JOURNAL OF GENETICS AND GENOMICS (2016)
CRISPR-mediated Genome Editing Restores Dystrophin Expression and Function in mdx Mice
Li Xu et al.
MOLECULAR THERAPY (2016)
Genome-wide analysis reveals specificities of Cpf1 endonucleases in human cells
Daesik Kim et al.
NATURE BIOTECHNOLOGY (2016)
A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice
Yang Yang et al.
NATURE BIOTECHNOLOGY (2016)
Selection-free gene repair after adenoviral vector transduction of designer nucleases: rescue of dystrophin synthesis in DMD muscle cell populations
Ignazio Maggio et al.
NUCLEIC ACIDS RESEARCH (2016)
Adenoviral vectors encoding CRISPR/Cas9 multiplexes rescue dystrophin synthesis in unselected populations of DMD muscle cells
Ignazio Maggio et al.
SCIENTIFIC REPORTS (2016)
Viral Vectors for Gene Therapy: Translational and Clinical Outlook
Melissa A. Kotterman et al.
ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 17 (2015)
Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
Bernd Zetsche et al.
CELL (2015)
Nanoparticle-based technologies for retinal gene therapy
Jeffrey Adijanto et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
Adenovirus-Mediated Somatic Genome Editing of Pten by CRISPR/Cas9 in Mouse Liver in Spite of Cas9-Specific Immune Responses
Dan Wang et al.
HUMAN GENE THERAPY (2015)
Inhibition of HIV-1 infection of primary CD4(+) T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR/Cas9
Chang Li et al.
JOURNAL OF GENERAL VIROLOGY (2015)
Gene Augmentation Therapy Restores Retinal Function and Visual Behavior in a Sheep Model of CNGA3 Achromatopsia
Eyal Banin et al.
MOLECULAR THERAPY (2015)
In vivo genome editing using Staphylococcus aureus Cas9
F. Ann Ran et al.
NATURE (2015)
Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors
Xiaoling Wang et al.
NATURE BIOTECHNOLOGY (2015)
Digenome-seq: genome-wide profiling of CRISPR-Cas9 off-target effects in human cells
Daesik Kim et al.
NATURE METHODS (2015)
Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria
Ido Yosef et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
A CRISPR-Based Screen Identifies Genes Essential for West-Nile-Virus-Induced Cell Death
Hongming Ma et al.
CELL REPORTS (2015)
Gene Therapy of ABCA4-Associated Diseases
Alberto Auricchio et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)
In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9
Lukasz Swiech et al.
NATURE BIOTECHNOLOGY (2015)
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Shengdar Q. Tsai et al.
NATURE BIOTECHNOLOGY (2015)
Development and Applications of CRISPR-Cas9 for Genome Engineering
Patrick D. Hsu et al.
CELL (2014)
Permanent Alteration of PCSK9 With In Vivo CRISPR-Cas9 Genome Editing
Qiurong Ding et al.
CIRCULATION RESEARCH (2014)
Triple Trans-Splicing Adeno-Associated Virus Vectors Capable of Transferring the Coding Sequence for Full-Length Dystrophin Protein into Dystrophic Mice
Taeyoung Koo et al.
HUMAN GENE THERAPY (2014)
In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system
Danilo Maddalo et al.
NATURE (2014)
DNA interrogation by the CRISPR RNA-guided endonuclease Cas9
Samuel H. Sternberg et al.
NATURE (2014)
Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library
Hiroko Koike-Yusa et al.
NATURE BIOTECHNOLOGY (2014)
Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases
Robert J. Citorik et al.
NATURE BIOTECHNOLOGY (2014)
Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing
Dirk Heck et al.
NATURE BIOTECHNOLOGY (2014)
Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials
David Bikard et al.
NATURE BIOTECHNOLOGY (2014)
Improved vectors and genome-wide libraries for CRISPR screening
Neville E. Sanjana et al.
NATURE METHODS (2014)
Phylogeny of Cas9 determines functional exchangeability of dual-RNA and Cas9 among orthologous type II CRISPR-Cas systems
Ines Fonfara et al.
NUCLEIC ACIDS RESEARCH (2014)
Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vector
Ami M. Kabadi et al.
NUCLEIC ACIDS RESEARCH (2014)
Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
Ophir Shalem et al.
SCIENCE (2014)
Genetic Screens in Human Cells Using the CRISPR-Cas9 System
Tim Wang et al.
SCIENCE (2014)
Retinal gene therapy with a large MYO7A cDNA using adeno-associated virus
V. S. Lopes et al.
GENE THERAPY (2013)
A largely random AAV integration profile after LPLD gene therapy
Christine Kaeppel et al.
NATURE MEDICINE (2013)
Nucleotide-resolution DNA double-strand break mapping by next-generation sequencing
Nicola Crosetto et al.
NATURE METHODS (2013)
Genome engineering using the CRISPR-Cas9 system
F. Ann Ran et al.
NATURE PROTOCOLS (2013)
Protospacer recognition motifs: Mixed identities and functional diversity
Shiraz A. Shah et al.
RNA BIOLOGY (2013)
DNA nanoparticle-mediated ABCA4 delivery rescues Stargardt dystrophy in mice
Zongchao Han et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
Martin Jinek et al.
SCIENCE (2012)
Phage therapy: concept to cure
Eric C. Keen
FRONTIERS IN MICROBIOLOGY (2012)
State-of-the-Art Lentiviral Vectors for Research Use: Risk Assessment and Biosafety Recommendations
Katia Pauwels et al.
CURRENT GENE THERAPY (2009)
A 16-bp RBE element mediated Rep-dependent site-specific integration in AAVS1 transgenic mice for expression of hFIX
Z. X. Xu et al.
GENE THERAPY (2009)
A hybrid vector system expands adeno-associated viral vector packaging capacity in a transgene-independent manner
Arkasubhra Ghosh et al.
MOLECULAR THERAPY (2008)
Stable gene transfer to muscle using non-integrating lentiviral vectors
Luis Apolonia et al.
MOLECULAR THERAPY (2007)
Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo
Stephanie Philippe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Effective gene therapy with nonintegrating lentiviral vectors
RJ Yáñez-Muñoz et al.
NATURE MEDICINE (2006)
Inverted terminal repeat sequences are important for intermolecular recombination and circularization of adeno-associated virus genomes
ZY Yan et al.
JOURNAL OF VIROLOGY (2005)
Adenoviruses as vaccine vectors
N Tatsis et al.
MOLECULAR THERAPY (2004)
Immune response following intraocular delivery of recombinant viral vectors
J Bennett
GENE THERAPY (2003)
Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo
Z Wang et al.
GENE THERAPY (2003)
Improved system for helper-dependent adenoviral vector production
D Palmer et al.
MOLECULAR THERAPY (2003)
Share Paper
